Experienced operational executive to lead Benuvia Manufacturing in its next stage of growth
Posted: October 26, 2021 at 10:00 a.m. CDT|Update: 16 minutes ago
ROUND ROCK, Texas, October 26, 2021 / PRNewswire / – Benuvia Manufacturing, Inc., a leading contract development and manufacturing (CDMO) organization, today announced the appointment of K. Scott aladeen as the first COO. Mr. Aladeen will oversee all company operations and be responsible for advancing Benuvia Manufacturing’s growth plans in the United States. He will be based at the company’s headquarters in Round Rock, Texas.
“We are delighted to welcome Scott at a time when we see a high demand for active pharmaceutical ingredients and pharmaceuticals,” said Todd C. Davis, executive chairman of Benuvia Manufacturing. “Scott’s extensive experience in industry and operations makes him the ideal candidate to take on this new role at such an exciting time for our company. “
Mr. Aladeen has four decades of pharmaceutical experience with deep expertise in executive leadership, operations management, quality assurance and control, manufacturing, supply chain and product development. He has worked in a wide range of industry sub-sectors, from brand name pharmaceuticals, generic drugs and CDMO services to the preparation of outsourced sterile drugs (503b pharmacy services) and a list of leading companies including AmerisourceBergen, Astellas Pharma US, Boehringer Ingelheim and Sanofi. Most recently, he held senior positions at QuVa Pharma and Avara Pharmaceutical Services, a CDMO that produces a range of pharmaceutical products. Mr. Aladeen began his career as a laboratory chemist developing analytical methods for new pharmaceuticals.
“I am proud to join this incredible team during a time of transformation for the CDMO industry,” commented Mr. Aladeen. “Benuvia Manufacturing is one of the leading organizations in this market and I look forward to supporting the company on its path to growth.
About Benuvia Manufacturing, Inc.
Benuvia Manufacturing, Inc. is a private, FDA registered, DEA (Annex IV) licensed cGMP manufacturing facility covering everything from API production to formulation to drug production, packaging, stability and distribution. With extensive experience in clinical and commercial stage cannabinoid production, entheogen production, research and development activities, Benuvia Manufacturing is at the forefront of these fascinating therapeutic areas. For more information visit www.benuviamanufacturing.com.
View original content to download multimedia:
SOURCE Benuvia Manufacturing
The above press release has been provided courtesy of PRNewswire. The views, opinions and statements contained in the press release are not endorsed by Gray Media Group and do not necessarily state or reflect those of Gray Media Group, Inc.